HOME >> MEDICINE >> NEWS
More studies on risks and benefits of COX-2 inhibitors published in Archives of Internal Medicine

CHICAGO -- A group of studies published in the January 24 issue of Archives of Internal Medicine add to the growing body of medical literature about the cardiovascular risks that may be associated with the class of pain-relieving drugs known as COX-2 inhibitors. Archives of Internal Medicine is one of the JAMA/Archives journals.

The Celecoxib Rofecoxib Efficacy and Safety in Comorbodities Evaluation Trial (CRESCENT) evaluated the effects of the COX-2 inhibitors and naproxen on 24-hour blood pressure readings in patients with type 2 diabetes, hypertension, and osteoarthritis. Patients were randomly assigned to receive 200 mg of celecoxib (Celebrex; Pfizer Inc., New York) [n= 136], or 25 mg of rofecoxib once daily (Vioxx, Merck & Co., West Point, Penn.) [n = 138], or 500 mg of naproxen twice daily (Naprosyn; Roche Pharmaceuticals, Basel, Switzerland) [n = 130] for 12 weeks. A total of 65 centers from 7 countries participated in this trial from May 2001 to April 2002. Patient evaluations were conducted at the start of the study and 1, 2, 6, and 12 weeks after randomization.

"Reductions in osteoarthritis symptoms, including pain, mobility, and stiffness, were similar in all treatment groups," the researchers found. "The mean (average) 24-hour systolic [top number in blood pressure reading] blood pressure following 6-weeks of therapy was increased significantly by refecoxib but not by celecoxib or naproxen."

"these results suggest the need for careful monitoring and control of blood pressure when NSAIDS (non-steroidal anti-inflammatory drugs) or COX-2 inhibitors are chosen for osteoarthritis management for patients with hypertension and type 2 diabetes and further suggest need for careful evaluation of currently available as well as future COX-2-specific inhibitors and nonspecific NSAIDs in this population," the authors conclude.

(Arch Intern Med. 2005; 165: 161-168. Available post-embargo at

Contact: Jane Shaskan
860-679-4777
JAMA and Archives Journals
24-Jan-2005


Page: 1 2 3 4 5

Related medicine news :

1. New studies suggest airborne SARS transmission is possible
2. New studies show mixed results on epilepsy drugs and birth defects
3. Brain imaging studies investigate pain reduction by hypnosis
4. Impact of scientific advances on drug studies and membrane research to be explored
5. Two studies find evidence that sunlight may have beneficial influence on cancer
6. Animal studies show stem cells might make biological pacemaker
7. Infants, children prefer sounds over pictures and only slowly become visually oriented, studies find
8. New studies on Ritalin and Alzheimers Disease highlight ACNP Annual Meeting
9. Gender and sex hormones affect the brains pain response and more, according to new studies
10. Analysis of tamoxifen studies reveals slight increase of stroke risk
11. Imaging studies clarify brain changes associated with language deficits in autism

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/24/2020)... (PRWEB) , ... June 24, 2020 , ... Evolved Naturals, ... launched a new website at http://www.evolvednaturals.com The newly launched website showcases a ... broad-spectrum CBD oils , and a comprehensive line of skincare & topical products ...
(Date:6/24/2020)... ... June 24, 2020 , ... ... management, today announced that Wexford Physician Hospital Organization (PHO) has successfully deployed SPH’s ... goals within the framework of value-based care. Use of Population Care is benefitting ...
(Date:6/24/2020)... , ... June 24, 2020 , ... ... frenectomies for those with lip ties and tongue ties as well as ... offers a collaborative approach to care with multispecialty teams including myofunctional therapists and ...
(Date:6/23/2020)... ... June 23, 2020 , ... Rritual , the premium brand in ... been named as the President of North America’s leading mushroom adaptogens company. , ... owning and operating his own family medicine clinic in London, Ontario, Canada where he ...
(Date:6/23/2020)... ... June 22, 2020 , ... ... new construction and renovation projects in 11 categories this year: 55+, Active ... International, Renovation/Repositioning, Skilled Nursing/Post-Acute Care and Standalone Memory Care. , “Particularly ...
Breaking Medicine News(10 mins):
(Date:6/23/2020)... SETAUKET, N.Y. (PRWEB) , ... June 23, 2020 ... ... Thailand was completed on May 11, 2020 which now features a greatly enlarged ... the hospital’s new concrete below-grade basement structures, water tanks, and rooftop garden. , ...
(Date:6/19/2020)... (PRWEB) , ... June 19, 2020 , ... The Covid-19 ... a top priority. Establishing a safe environment and compliant workforce is critical in the ... SupplyPro is offering its popular SupplyBay vending machine below cost for a limited time ...
(Date:6/19/2020)... ... June 19, 2020 , ... ... cross-platform campaign 'Clinical Trials.' This campaign showcases the innovative medical research achieved ... thereby advancing knowledge and disease treatment. This public awareness campaign aims to ...
Breaking Medicine Technology:
Cached News: